Freespira an effective treatment for PTSD and panic disorder, real-world study confirms

Patients remained highly engaged during the four-week course of treatment, and about two-thirds of all patients experienced a significant drop in symptom severity KIRKLAND, Wash., Nov. 30, 2022 /PRNewswire/ — Freespira, Inc., developer of the only FDA-cleared treatment for symptoms of…

Click here to view original post